Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pentoxifylline Effect on Renal Function, Oxidative Stress, Inflammation, and Fibrosis Markers, and Quality of Life in Patients With Diabetic Nephropathy

NCT03664414 is registered in ClinicalTrials.gov with Maria Eugenia Galván Plata as lead sponsor.

NCT NCT03664414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03664414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pentoxifylline Effect on Renal Function, Oxidative Stress, Inflammation, and Fibrosis Markers, and Quality of Life in Patients With Diabetic Nephropathy
Lead sponsor
Maria Eugenia Galván Plata
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2018
Completion date
December 31, 2021
Enrollment
196 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage3 and 4, type 2 diabetes mellitus